Read + Share
Maeder MT. The beta3-adrenoreceptor agonist mirabegron for the treatment of combined pre- and
post-capillary pulmonary hypertension: new pathway or dead end? Eur J Heart Fail 2023 Jan 24. doi: 10.1002/ejhf.2780.
PMID: 36691743
|
 |
|
Maeder MT. The beta3-adrenoreceptor agonist mirabegron for the treatment of combined pre- and
post-capillary pulmonary hypertension: new pathway or dead end? Eur J Heart Fail 2023 Jan 24. doi: 10.1002/ejhf.2780.
PMID: 36691743
|
|
|
|